- Home
- Publications
- Publication Search
- Publication Details
Title
Alternative therapies against Mycobacterium abscessus infections
Authors
Keywords
-
Journal
CLINICAL MICROBIOLOGY AND INFECTION
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-11-04
DOI
10.1016/j.cmi.2023.10.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin
- (2023) Ivana Palucci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Biotin-dependent cell envelope remodelling is required for Mycobacterium abscessus survival in lung infection
- (2023) Mark R. Sullivan et al. Nature Microbiology
- Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria
- (2023) Matteo Mori et al. Pharmaceutics
- Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease
- (2023) Sarah A.R. Siegel et al. CHEST
- Eradication of Mycobacterium abscessus infection in cystic fibrosis with initiation of Elexacaftor/Tezacaftor/Ivacaftor
- (2023) Caoimhe McParland et al. Journal of Cystic Fibrosis
- Efficacy of PBTZ169 and pretomanid against Mycobacterium avium, Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum in BALB/c mice models
- (2023) Luyao Zheng et al. Frontiers in Cellular and Infection Microbiology
- Mycobacterial biotin biosynthesis counters airway alkalinity
- (2023) Wassim Daher et al. Nature Microbiology
- Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in Mycobacterium abscessus
- (2022) Juan Manuel Belardinelli et al. Science Translational Medicine
- Combined Host- and Pathogen-Directed Therapy for the Control of Mycobacterium abscessus Infection
- (2022) Noemi Poerio et al. Microbiology Spectrum
- Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection
- (2022) Jerry A. Nick et al. CELL
- A Novel Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Expresses Anti-Mycobacterium abscessus Activity In Vitro and In Vivo
- (2022) Wenye Wu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phage Therapy of Mycobacterium Infections: Compassionate-use of Phages in Twenty Patients with Drug-Resistant Mycobacterial Disease
- (2022) Rebekah M. Dedrick et al. CLINICAL INFECTIOUS DISEASES
- Investigating the Antituberculosis Activity of Selected Commercial Essential Oils and Identification of Active Constituents Using a Biochemometrics Approach and In Silico Modeling
- (2022) Katyna J. Boussamba-Digombou et al. Antibiotics-Basel
- Mycobacterium abscessus Mutants with a Compromised Functional Link between the Type VII ESX-3 System and an Iron Uptake Mechanism Reliant on an Unusual Mycobactin Siderophore
- (2022) Glennon V. Bythrow et al. Pathogens
- In Vitro and In Vivo Activity of Gepotidacin against Drug-Resistant Mycobacterial Infections
- (2022) Mohammad Naiyaz Ahmad et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Preclinical murine models to study lung infection with Mycobacterium abscessus complex
- (2022) Francesca Nicola et al. TUBERCULOSIS
- Host‐directed therapy to combat mycobacterial infections*
- (2021) Gül Kilinç et al. IMMUNOLOGICAL REVIEWS
- Beyond phenotype: The genomic heterogeneity of co-infecting Mycobacterium abscessus smooth and rough colony variants in cystic fibrosis patients
- (2021) Ana Victoria Gutiérrez et al. Journal of Cystic Fibrosis
- Pipeline of anti‐ Mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities
- (2021) Anna Egorova et al. MEDICINAL RESEARCH REVIEWS
- Stepwise pathogenic evolution of Mycobacterium abscessus
- (2021) Josephine M. Bryant et al. SCIENCE
- Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance
- (2021) Rebekah M. Dedrick et al. mBio
- Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis
- (2021) Stefanie Krug et al. Frontiers in Immunology
- Phage Therapy for Antibiotic-Resistant Bacterial Infections
- (2021) Graham F. Hatfull et al. Annual Review of Medicine
- Mycobacteriophage–antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus
- (2021) Matt D. Johansen et al. Disease Models & Mechanisms
- The Antimalarial Mefloquine Shows Activity against Mycobacterium abscessus, Inhibiting Mycolic Acid Metabolism
- (2021) Giulia Degiacomi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clomiphene Citrate Shows Effective and Sustained Antimicrobial Activity against Mycobacterium abscessus
- (2021) Da-Gyum Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mycobacteria–host interactions in human bronchiolar airway organoids
- (2021) Nino Iakobachvili et al. MOLECULAR MICROBIOLOGY
- Antibacterial peptide RP557 increases the antibiotic sensitivity of Mycobacterium abscessus by inhibiting biofilm formation
- (2021) Bing Li et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Improving the Drug Development Pipeline for Mycobacteria: Modelling Antibiotic Exposure in the Hollow Fibre Infection Model
- (2021) Arundhati Maitra et al. Antibiotics-Basel
- Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus
- (2020) Matt D. Johansen et al. NATURE REVIEWS MICROBIOLOGY
- Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus
- (2020) Rose C. Lopeman et al. Scientific Reports
- Untargetted Metabolomic Exploration of the Mycobacterium tuberculosis Stress Response to Cinnamon Essential Oil
- (2020) Elwira Sieniawska et al. Biomolecules
- Rifabutin is bactericidal against intracellular and extracellular forms of Mycobacterium abscessus
- (2020) Matt D. Johansen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Alternative and Experimental Therapies of Mycobacterium abscessus Infections
- (2020) Michal Meir et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Repurposing disulfiram to target infections caused by non-tuberculous mycobacteria
- (2019) Swetarka Das et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections
- (2019) Brandon Banaschewski et al. Journal of Cystic Fibrosis
- Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
- (2019) Rebekah M. Dedrick et al. NATURE MEDICINE
- Rifabutin is active against Mycobacterium abscessus in mice
- (2019) Thomas Dick et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pretomanid: First Approval
- (2019) Susan J. Keam DRUGS
- Ginger essential oil and fractions against Mycobacterium spp.
- (2019) Vanessa Pietrowski Baldin et al. JOURNAL OF ETHNOPHARMACOLOGY
- Host Directed Therapies for Tuberculosis: Futures Strategies for an Ancient Disease
- (2018) Ivana Palucci et al. CHEMOTHERAPY
- Inhaled granulocyte–macrophage colony-stimulating factor forMycobacterium abscessusin cystic fibrosis
- (2018) John P. Scott et al. EUROPEAN RESPIRATORY JOURNAL
- Identification of genes required forMycobacterium abscessusgrowth in vivo with a prominent role of the ESX-4 locus
- (2018) Laura Laencina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adjunctive use of celecoxib with anti-tuberculosis drugs: evaluation in a whole-blood bactericidal activity model
- (2018) Claire M. Naftalin et al. Scientific Reports
- “In vitro” activity of Melaleuca cajuputi against mycobacterial species
- (2018) Alessandra Bua et al. NATURAL PRODUCT RESEARCH
- MmpL8MAB controls Mycobacterium abscessus virulence and production of a previously unknown glycolipid family
- (2018) Violaine Dubois et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibiofilm activity of nanoemulsions of Cymbopogon flexuosus against rapidly growing mycobacteria
- (2017) Grazielle Guidolin Rossi et al. MICROBIAL PATHOGENESIS
- Compassionate Nitric Oxide Adjuvant Treatment of Persistent Mycobacterium Infection in Cystic Fibrosis Patients
- (2017) Karin Yaacoby-Bianu et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers
- (2016) Robert S Wallis et al. LANCET INFECTIOUS DISEASES
- Deletion of a dehydratase important for intracellular growth and cording renders roughMycobacterium abscessusavirulent
- (2016) Iman Halloum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Novel Therapeutic Approach Using Mesenchymal Stem Cells to Protect Against Mycobacterium abscessus
- (2016) Jong-Seok Kim et al. STEM CELLS
- Modeling the Mycobacterium tuberculosis Granuloma – the Critical Battlefield in Host Immunity and Disease
- (2013) Evelyn Guirado et al. Frontiers in Immunology
- In vitroeffects of citrus oils againstMycobacterium tuberculosisand non-tuberculousMycobacteriaof clinical importance
- (2012) Philip G. Crandall et al. JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART B-PESTICIDES FOOD CONTAMINANTS AND AGRICULTURAL WASTES
- Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae
- (2011) S. Chopra et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Inhibition of Bacterial Multidrug Resistance by Celecoxib, a Cyclooxygenase-2 Inhibitor
- (2010) Arunasree M. Kalle et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now